Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 6/20 | 0.36 |
| ▸ | ESR2 | Q92731 | 6/20 | 0.36 |
| ▸ | MAPT | P10636 | 4/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 4/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | POLB | P06746 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | HPGD | P15428 | 2/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.35 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.35 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15672172 | 0.86 | DHFR (0.42) | MAPTKDM4ETDP1L3MBTL1LMNA | |
| SCHEMBL14701342 | 0.86 | ALDH1A1 (0.33) | MAPTKDM4ETDP1L3MBTL1LMNA | |
| SCHEMBL20080392 | 0.82 | KDM4E (0.41) | ESR1ESR2MAPTKDM4ETDP1 | |
| SCHEMBL15086106 | 0.81 | ESR1 (0.39) | ESR1ESR2MAPTKDM4ETDP1 | |
| SCHEMBL13555444 | 0.81 | DHFR (0.41) | MAPTKDM4ETDP1L3MBTL1MAPK1 | |
| SCHEMBL13454246 | 0.80 | PRMT5 (0.42) | ESR1ESR2MAPTKDM4ETDP1 | |
| SCHEMBL15672167 | 0.80 | GPR3 (0.34) | ESR1ESR2MAPTKDM4ETDP1 | |
| SCHEMBL21202669 | 0.80 | KDM4E (0.42) | KDM4EL3MBTL1LMNAMEN1KMT2A | |
| SCHEMBL13555451 | 0.79 | BRD4 (0.40) | MAPTKDM4EL3MBTL1LMNAALDH1A1 | |
| SCHEMBL21241626 | 0.79 | KDM4E (0.39) | ESR1ESR2MAPTKDM4ETDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10804472-B2 | Light-emitting element, light-emitting device, light source, authentication device, and electronic apparatus | SEIKO EPSON CORPORATION (JP) | 2020-10-13 | — | — | US | disclosed |
| US-10367148-B2 | Light-emitting device, electronic apparatus, and inspection method | SEIKO EPSON CORPORATION (JP) | 2019-07-30 | — | — | US | disclosed |
| US-9741940-B2 | Thiadiazole, light-emitting element, light-emitting apparatus, authentication apparatus, and electronic device | SEIKO EPSON CORPORATION (JP) | 2017-08-22 | — | — | US | disclosed |
| US-9741940-B2 | Thiadiazole, light-emitting element, light-emitting apparatus, authentication apparatus, and electronic device | SEIKO EPSON CORPORATION (JP) | 2017-08-22 | — | — | US | disclosed |
| US-20160359117-A1 | LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AUTHENTICATION DEVICE, AND ELECTRONIC APPARATUS | SEIKO EPSON CORPORATION (JP) | 2016-12-08 | — | — | US | disclosed |
| US-20160359117-A1 | LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AUTHENTICATION DEVICE, AND ELECTRONIC APPARATUS | SEIKO EPSON CORPORATION (JP) | 2016-12-08 | — | — | US | disclosed |
| US-9401460-B2 | Light emitting element | SEIKO EPSON CORPORATION (JP) | 2016-07-26 | — | — | US | disclosed |
| US-9401460-B2 | Light emitting element | SEIKO EPSON CORPORATION (JP) | 2016-07-26 | — | — | US | disclosed |
| US-9224928-B2 | Light emitting element, light emitting device and electronic apparatus | SEIKO EPSON CORPORATION (JP) | 2015-12-29 | — | — | US | disclosed |
| US-9224928-B2 | Light emitting element, light emitting device and electronic apparatus | SEIKO EPSON CORPORATION (JP) | 2015-12-29 | — | — | US | disclosed |
| US-20140332835-A1 | LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE AND ELECTRONIC APPARATUS | SEIKO EPSON CORPORATION (JP) | 2014-11-13 | — | — | US | disclosed |
| US-20140332835-A1 | LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE AND ELECTRONIC APPARATUS | SEIKO EPSON CORPORATION (JP) | 2014-11-13 | — | — | US | disclosed |
| US-8803138-B2 | Light emitting element, light emitting device and electronic apparatus | SEIKO EPSON CORPORATION (JP) | 2014-08-12 | — | — | US | disclosed |
| US-8803138-B2 | Light emitting element, light emitting device and electronic apparatus | SEIKO EPSON CORPORATION (JP) | 2014-08-12 | — | — | US | disclosed |
| US-20130168654-A1 | LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE AND ELECTRONIC APPARATUS | SEIKO EPSON CORPORATION (JP) | 2013-07-04 | — | — | US | disclosed |
| US-20130168654-A1 | LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE AND ELECTRONIC APPARATUS | SEIKO EPSON CORPORATION (JP) | 2013-07-04 | — | — | US | disclosed |
| US-20130037784-A1 | THIADIAZOLE, LIGHT-EMITTING ELEMENT, LIGHT-EMITTING APPARATUS, AUTHENTICATION APPARATUS, AND ELECTRONIC DEVICE | SEIKO EPSON CORPORATION (JP) | 2013-02-14 | — | — | US | disclosed |
| US-20130037784-A1 | THIADIAZOLE, LIGHT-EMITTING ELEMENT, LIGHT-EMITTING APPARATUS, AUTHENTICATION APPARATUS, AND ELECTRONIC DEVICE | SEIKO EPSON CORPORATION (JP) | 2013-02-14 | — | — | US | disclosed |
| US-20130037785-A1 | LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, AND ELECTRONIC DEVICE | SEIKO EPSON CORPORATION (JP) | 2013-02-14 | — | — | US | disclosed |
| US-20130037785-A1 | LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, AND ELECTRONIC DEVICE | SEIKO EPSON CORPORATION (JP) | 2013-02-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130037784-A1 | THIADIAZOLE, LIGHT-EMITTING ELEMENT, LIGHT-EMITTING APPARATUS, AUTHENTICATION APPARATUS, AND ELECTRONIC DEVICE | CYP3A4, CYP2E1, TH | ESR1 1341/4885ESR2 470/4885MAPT 3092/4885 |
| US-10367148-B2 | Light-emitting device, electronic apparatus, and inspection method | CRY1, INF2, CRY2 | ESR1 66/4885ESR2 249/4885MAPT 3723/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.